Send to

Choose Destination
Int J Cardiol. 2013 Sep 10;167(6):2462-7. doi: 10.1016/j.ijcard.2013.01.028. Epub 2013 Feb 12.

Cost analysis of radiofrequency catheter ablation for atrial fibrillation.

Author information

Department of Cardiology, Faculty of Medicine, Osmangazi Eskisehir University, Eskisehir, Turkey.


Atrial fibrillation is the most common arrhythmia associated with increased mortality and morbidity. Its management requires high healthcare expenditures; 52%-70% of expenses for AF care are constituted by hospitalization costs. The current management strategies of pharmacological rhythm control and pharmacological or invasive rate control show no difference in impact on major outcomes in patients with AF. Radiofrequency catheter ablation (RFA) has been shown to reduce the risk of AF recurrence, improve quality of life and reduce hospitalization rate as compared to pharmacological rhythm control and rate control strategies. This review summarizes current knowledge on cost and cost-effectiveness analysis of RFA for patients with atrial fibrillation.


Atrial fibrillation; Cost analysis; Cost-effectiveness analysis; Outcomes; Radiofrequency catheter ablation

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center